Enzymatic RNA synthesis paves the way for sustainable therapeutics |
|
|
|
|
|
|
The latest muscular dystrophy news from News Medical |
|
|
|
|
|
| | Indiana University School of Medicine researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD). | | | | While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis. | |
|
|
|
|